Weihua New Material(603310)

Search documents
巍华新材(603310) - 2024年度独立董事述职报告(邹海魁)
2025-04-28 13:00
浙江巍华新材料股份有限公司 2024 年度独立董事述职报告 (邹海魁) 本人作为浙江巍华新材料股份有限公司(以下简称"公司"或"巍华新材") 的独立董事,严格按照《公司法》《上市公司独立董事管理办法》等相关法律法 规和《公司章程》《独立董事工作细则》的规定和要求,在 2024 年度认真履行独 立董事职责,致力于维护公司和股东,尤其是中小股东的合法权益。现就 2024 年度独立董事履职情况述职如下: 一、独立董事的基本情况 (一)独立董事简介 邹海魁先生,1973 年 2 月出生,中国国籍,无境外永久居留权,博士研究 生学历。2002 年 7 月至 2005 年 12 月任北京化工大学讲师,2006 年 1 月至 2017 年 12 月任北京化工大学副研究员、研究员,2018 年 1 月至今任北京化工大学教 授、博士生导师,2021 年 5 月至今担任巍华新材独立董事。 (二)独立性情况 作为巍华新材的独立董事,本人未在公司担任除独立董事以外的其他任何职 务,未在公司主要股东单位担任任何职务,与公司及公司主要股东或有利害关系 的机构和人员不存在可能妨碍本人进行独立客观判断的关系,没有从公司及公司 主要股东或有利 ...
巍华新材(603310) - 2024 Q4 - 年度财报
2025-04-28 12:55
Financial Performance - The company's operating revenue for 2024 was CNY 1,107,498,711.64, a decrease of 25.47% compared to CNY 1,485,931,778.72 in 2023[23]. - The net profit attributable to shareholders for 2024 was CNY 253,593,985.67, down 49.24% from CNY 499,549,151.46 in 2023[23]. - The basic earnings per share for 2024 was CNY 0.88, a decline of 54.40% compared to CNY 1.93 in 2023[24]. - The company's total assets increased to CNY 4,585,115,204.82 in 2024, up 64.07% from CNY 2,794,618,242.49 in 2023[23]. - The net cash flow from operating activities for 2024 was CNY 223,269,699.62, a decrease of 48.72% from CNY 435,415,749.05 in 2023[23]. - The company's gross profit for 2024 was 344.98 million yuan, a year-on-year decline of 49.13%, with a comprehensive gross margin dropping from 45.64% to 31.15%[49]. - The decline in performance was attributed to insufficient market demand and price declines due to cyclical fluctuations in the industry[50]. Dividend Policy - The company plans to distribute a cash dividend of 3.00 yuan per 10 shares (including tax) based on the total share capital as of the dividend distribution date, with a cumulative undistributed profit of 1,373,783,646.74 yuan as of December 31, 2024[6]. - The company has established a cash dividend policy, ensuring that at least 25% of the net profit attributable to the parent company is distributed as cash dividends each year[155]. - For the fiscal year 2024, the company intends to distribute a cash dividend of 3.00 CNY per 10 shares, amounting to a total of 103,602,000 CNY, which represents 95.32% of the net profit attributable to shareholders[165][168]. - The total cash dividend for the year, including interim distributions, is projected to be 241,738,000 CNY, also accounting for 95.32% of the net profit attributable to shareholders[168]. - The company will not distribute profits until it has covered any previous losses and allocated the required legal reserve[156]. Risk Management - There are no significant risks that materially affect the company's production and operations during the reporting period[8]. - The company has not faced any major risks that could impact its future development, as detailed in the management discussion and analysis section[8]. - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties[8]. - The company has not violated decision-making procedures for providing guarantees to external parties[8]. - The company has no reported risks identified by the supervisory board during the reporting period[149]. Research and Development - The company is actively developing new projects and technologies, applying for 6 invention patents and obtaining 5 authorized patents in 2024[34]. - The average R&D expenditure over the past three years was approximately 57.39 million yuan, accounting for 3.94% of the average annual revenue during the same period[41]. - The company invested 46.85 million RMB in R&D, accounting for 4.23% of total revenue, and holds 41 patents, including 22 invention patents[96]. - The company employs 118 R&D and technical personnel, most of whom have backgrounds in chemical engineering or related fields[41]. - The company has successfully developed various fluorinated fine chemical intermediates through innovative synthesis processes, enhancing resource utilization[95]. Environmental Commitment - The company emphasizes the importance of environmental protection and has received multiple awards for its green factory initiatives, enhancing its sustainable development strategy[48]. - The company has established a comprehensive pollution control system for wastewater, waste gas, and solid waste, ensuring compliance with environmental standards[182]. - The company has committed to continuous technological innovation, aiming to become a green benchmark in the fine chemical industry[184]. - The company has developed patented technologies that significantly reduce energy consumption and emissions during production processes[184]. - The company is actively pursuing a circular economy model to enhance resource utilization and reduce carbon emissions[184]. Corporate Governance - The board of directors and supervisory board members confirm the authenticity, accuracy, and completeness of the annual report[3]. - The company maintains independence from its controlling shareholders in assets, personnel, finance, and operations, ensuring a complete and independent business system[124]. - The company has established independent governance structures, including a board of directors and supervisory board, which operate independently from its shareholders[125]. - The company adheres to strict information disclosure obligations, ensuring that all shareholders have equal access to relevant information[123]. - The company has a clear organizational structure that separates its operations from those of its controlling shareholders, ensuring no mixed operations[126]. Market Position and Strategy - The company operates in the fluorochemical industry, focusing on the research, production, and sales of chlorobenzene and trifluoromethylbenzene series products[37]. - The company is one of the largest domestic producers of trifluoromethylbenzene series products, benefiting from stable supply capabilities and cost competitiveness[42]. - The company has established stable partnerships with renowned clients such as BAYER, BASF, and FMC, recognized for its product quality and reliable supply[45]. - The company is positioned as a leading player in the domestic market for trifluoromethylbenzene series products, with significant production capacity and a complete industrial chain[89]. - The company is expanding its market presence in Southeast Asia, targeting a 25% increase in market share by the end of the fiscal year[131].
巍华新材(603310) - 2025 Q1 - 季度财报
2025-04-28 12:55
Financial Performance - The company's operating revenue for Q1 2025 was CNY 190,979,383.91, a decrease of 38.45% compared to CNY 310,266,374.74 in the same period last year[4] - Net profit attributable to shareholders was CNY 33,486,001.64, down 63.17% from CNY 90,918,722.70 year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 28,028,716.49, reflecting a decline of 68.37% compared to CNY 88,604,859.39 in the previous year[4] - Basic earnings per share decreased by 71.43% to CNY 0.10 from CNY 0.35 in the same period last year[5] - The total operating profit for Q1 2025 is CNY 38,832,099.18, a decrease of 63.3% from CNY 105,539,022.51 in Q1 2024[18] - The company reported a tax expense of CNY 7,888,392.71 for Q1 2025, compared to CNY 14,796,056.29 in Q1 2024[18] Cash Flow and Investments - The company reported a net cash flow from operating activities of CNY 22,455,475.95, down 18.35% from CNY 27,503,377.84 in the previous year[4] - The cash flow from operating activities for Q1 2025 is CNY 22,455,475.95, compared to CNY 27,503,377.84 in Q1 2024, indicating a decrease of 18.5%[22] - Investment cash inflow for Q1 2025 is CNY 523,256,924.60, significantly higher than CNY 20,700,834.17 in Q1 2024[22] - The net cash flow from investment activities in Q1 2025 is CNY 95,177,378.04, a recovery from a negative CNY 356,052,708.30 in Q1 2024[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,563,946,381.33, a slight decrease of 0.46% from CNY 4,585,115,204.82 at the end of the previous year[5] - Current assets totaled CNY 2,617,450,109.77 as of March 31, 2025, a slight decrease from CNY 2,694,955,168.71 at the end of 2024[12] - Non-current assets increased to CNY 1,946,496,271.56 from CNY 1,890,160,036.11, reflecting a growth of 3.0%[13] - Total liabilities were CNY 448,661,461.47, down from CNY 504,853,849.73, indicating a reduction of 11.1%[14] - Shareholders' equity increased to CNY 4,115,284,919.86 from CNY 4,080,261,355.09, reflecting a growth of 0.9%[14] Market Conditions - The decline in revenue and profit was attributed to industry cyclical fluctuations and increased market competition, impacting product pricing and profit margins[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,935[8]
巍华新材(603310) - 公司对会计师事务所2024年度履职情况评估报告
2025-04-28 12:52
一、2024 年年审会计师事务所基本情况 (一)会计师事务所基本情况 1、基本情况 立信会计师事务所(特殊普通合伙)由我国会计泰斗潘序伦博士于 1927 年 在上海创建,1986 年复办,2010 年成为全国首家完成改制的特殊普通合伙制会 计师事务所,注册地址为上海市,首席合伙人为朱建弟先生。立信是国际会计网 络 BDO 的成员所,长期从事证券服务业务,新证券法实施前具有证券、期货业 务许可证,具有 H 股审计资格,并已向美国公众公司会计监督委员会(PCAOB) 注册登记。 截至 2024 年末,立信拥有合伙人 296 名、注册会计师 2,498 名、从业人员 总数 10,021 名,签署过证券服务业务审计报告的注册会计师 743 名。 浙江巍华新材料股份有限公司 对会计师事务所 2024 年度履职情况评估报告 浙江巍华新材料股份有限公司(以下简称"公司")聘请立信会计师事务所 (特殊普通合伙)(以下简称"立信")作为公司 2024 年度审计机构。根据财政 部、国务院国资委及证监会颁布的《国有企业、上市公司选聘会计师事务所管理 办法》的要求,公司对立信 2024 年审计过程中的履职情况进行了评估,具体情 况如 ...
巍华新材(603310) - 2024年度主要经营数据公告
2025-04-28 12:52
证券代码:603310 证券简称:巍华新材 公告编号:2025-023 浙江巍华新材料股份有限公司 2024 年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号——行业信息披露》之 《第十三号——化工》的要求,浙江巍华新材料股份有限公司(以下简称"公司") 现将 2024 年度主要经营数据披露如下: 一、 主要产品的产量、销量及收入实现情况 2024 年度公司营业收入为 110,749.87 万元,其中主营业务收入为 109,673.39 万元,其他业务收入为 1,076.48 万元。公司主要产品产销情况如下: | 类别 | 产量(吨) | 销量(吨) | 销售收入 (万元) | 销量同比变 化(%) | 销售收入同 比变化(%) | | --- | --- | --- | --- | --- | --- | | 氯甲苯系列 | 68,220.25 | 32,265.68 | 27,204.07 | -1.11 | -23.38 | | 三氟甲基苯 系列 | ...
巍华新材(603310) - 2025 年第一季度主要经营数据公告
2025-04-28 12:52
证券代码:603310 证券简称:巍华新材 公告编号:2025-028 浙江巍华新材料股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号——行业信息披露》之 《第十三号——化工》的要求,浙江巍华新材料股份有限公司(以下简称"公司") 现将 2025 年第一季度主要经营数据披露如下: 一、 主要产品的产量、销量及收入实现情况 2025年1-3月公司营业收入为19,097.94万元,其中主营业务收入为18,883.59 万元,其他业务收入为 214.35 万元。公司主要产品产销情况如下: | 类别 | 产量(吨) | 销量(吨) | 销售收入 (万元) | 销量同比变 化(%) | 销售收入同 比变化(%) | | --- | --- | --- | --- | --- | --- | | 氯甲苯系列 | 6,949.56 | 5,426.57 | 4,116.64 | -27.85 | -41.80 | | 三氟甲基苯 系列 | ...
巍华新材(603310) - 关于召开2024年度业绩说明会的公告
2025-04-28 12:51
证券代码:603310 证券简称:巍华新材 公告编号:2025-018 浙江巍华新材料股份有限公司 关于召开 2024 年度业绩说明会的公告 本公司及董事会全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 会议召开时间:2025 年 5 月 13 日(星期二)下午 15:00-16:00 会 议 召 开 地 点 : 上 海 证 券 报 · 中 国 证 券 网 路 演 中 心 (https://roadshow.cnstock.com/) 会议召开方式:网络在线互动 投资者可于 2025 年 5 月 6 日(星期二) 至 5 月 12 日(星期一)16:00 前 将 相 关 问 题 通 过 电 子 邮 件 的 形 式 发 送 至 本 公 司 投 资 者 关 系 邮 箱 WHXC@weihua-newmaterial.com 或扫描下方二维码提交。公司将在说明会上就 投资者普遍关注的问题进行回答。 浙江巍华新材料股份有限公司(以下简称"公司")已于 2025 年 4 月 29 日发布了公司 2024 年年度报告,为便于广大投资者更 ...
巍华新材(603310) - 董事会审计委员会对会计师事务所履行监督职责情况报告
2025-04-28 12:51
一、2024 年年审会计师事务所基本情况 (一)会计师事务所基本情况 1、基本情况 浙江巍华新材料股份有限公司董事会审计委员会 对会计师事务所履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办法》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》和浙江巍华新材料股份有限公司(以下简 称"公司")《公司章程》《董事会审计委员会工作细则》等规定和要求,董事会 审计委员会本着勤勉尽责的原则,恪尽职守,认真履职。现将董事会审计委员会 对会计师事务所 2024 年度履行监督职责的情况汇报如下: 3、诚信记录 立信近三年因执业行为受到刑事处罚无、行政处罚 5 次、监督管理措施 43 次、自律监管措施 4 次和纪律处分无,涉及从业人员 131 名。 立信会计师事务所(特殊普通合伙)(以下简称"立信")由我国会计泰斗潘 序伦博士于 1927 年在上海创建,1986 年复办,2010 年成为全国首家完成改制的 特殊普通合伙制会计师事务所,注册地址为上海市,首席合伙人为朱建弟先生。 立信是国际会计网络 BDO 的成员所,长期从事证 ...
巍华新材(603310) - 关于向银行申请综合授信额度的公告
2025-04-28 12:51
证券代码:603310 证券简称:巍华新材 公告编号:2025-027 浙江巍华新材料股份有限公司 关于向银行申请综合授信额度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 浙江巍华新材料股份有限公司 2、授信申请人为公司或公司的全资、控股子公司; 3、授信额度为公司及公司的全资、控股子公司新增综合授信额度合计不超 过 200,000 万元人民币; 4、上述授信额度不等于公司的实际融资金额,实际融资金额将视公司运营 资金的实际需求确定,在授信额度内以金融机构与公司实际发生的融资金额为准。 5、上述融资方式包括但不限于流动资金借款、固定资产贷款、信托融资及 贸易融资等,融资担保方式为信用、保证、抵押及质押等,融资期限以实际签署 的合同为准。 2025 年 4 月 29 日 6、上述授信事项的有效期为董事会审议通过之日起 12 个月,授信额度在有 效期内可循环使用。在具体办理上述额度内的融资业务时,公司董事会授权公司 董事长或董事长指定的授权代理人代表公司签署上述授信额度内的一切授信(包 括但不限于授信、借款、担保、抵押、 ...